Lipella Pharmaceuticals Inc. (LIPO)

Lipella Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1.86	2.18	3.29	5.12	1.41	0.61
Short-Term Investments	-	-	-	-	0.3	-
Cash & Short-Term Investments	1.86	2.18	3.29	5.12	1.71	0.61
Cash Growth	37.09%	-33.67%	-35.69%	198.75%	182.56%	2233.15%
Other Receivables	-	0.08	0.03	0.11	-	0.07
Receivables	-	0.08	0.03	0.11	-	0.07
Prepaid Expenses	0.22	0.35	0.1	0.56	0.09	0.02
Total Current Assets	2.08	2.62	3.43	5.8	1.81	0.7
Property, Plant & Equipment	0.27	0.06	0.15	0.15	0.2	0.26
Total Assets	2.35	2.67	3.58	5.95	2.01	0.96

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	0.46	0.39	0.14	0.38	0.05	0.02
Accrued Expenses	0.14	0.32	0.16	0.46	0.23	0.11
Short-Term Debt	-	-	-	0.28	0.03	0.03
Current Portion of Leases	0.04	0.05	0.09	0.06	0.04	0.05
Other Current Liabilities	-	-	-	-	-	0
Total Current Liabilities	0.64	0.75	0.39	1.18	0.34	0.21
Long-Term Debt	-	-	-	-	0.05	0.05
Long-Term Leases	0.22	-	0.05	0.1	0.17	0.21
Other Long-Term Liabilities	-	-	-	-	0.03	0.03
Total Liabilities	0.86	0.75	0.43	1.27	0.59	0.49

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	20.72	17.26	13.47	10.38	4.53	1.7
Retained Earnings	-19.23	-15.34	-10.32	-5.7	-3.11	-1.24
Total Common Equity	1.49	1.92	3.14	4.68	1.42	0.46
Shareholders' Equity	1.49	1.92	3.14	4.68	1.42	0.46
Total Liabilities & Equity	2.35	2.67	3.58	5.95	2.01	0.96

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	0.26	0.05	0.14	0.43	0.28	0.33
Net Cash (Debt)	1.59	2.14	3.16	4.69	1.43	0.27
Net Cash Growth	24.07%	-32.30%	-32.71%	227.80%	420.77%	-
Net Cash Per Share	0.52	2.04	4.21	9.24	3.36	1.03
Filing Date Shares Outstanding	4.62	2.55	0.78	0.72	0.48	0.48
Total Common Shares Outstanding	4.62	1.21	0.76	0.72	0.48	0.29
Working Capital	1.44	1.86	3.04	4.62	1.47	0.49
Book Value Per Share	0.32	1.59	4.16	6.51	2.94	1.61
Tangible Book Value	1.49	1.92	3.14	4.68	1.42	0.46
Tangible Book Value Per Share	0.32	1.59	4.16	6.51	2.94	1.61
Machinery	0.14	0.14	0.14	0.13	-	-

Data Source: S&P Global Market Intelligence Last updated: Nov 14, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 8, 2026

Data Sources Report a data error